D’antuoni, J., Mazzeo, M. A., Penalba, R., Ross, S., Federico, F., Marquez Valdivia, N., Jenifer, R., Cortez Velasquez, J., Tellas, M., Tito, L., Neselis, M. S., Peloso, V., & Moiraghi, B. (2026). Is it possible to reduce the dose of tyrosine kinase inhibitors and maintain response in chronic-phase Philadelphia chromosome– positive chronic myeloid leukemia? A single-center experience. Journal of Hematology, 30(1), 63–71. https://doi.org/10.48057/hematologa.v30i1.703